NXGL

Nexgel Inc

NXGL, USA

NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also developing NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Lumagel Beauty, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.

https://nexgel.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
NXGL
stock
NXGL

NexGel Inc Announces Spin-Off of Drug Delivery Unit TipRanks

Read more →
NXGL
stock
NXGL

NEXGEL Announces Spin-Off of Drug Delivery Assets into NexGelRx with Equity Stake and Royalty Agreement Quiver Quantitative

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$6

Analyst Picks

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very High

2.81

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-12.59 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-5.62 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-27.03 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

1.17

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 11.00% of the total shares of Nexgel Inc

1.

Evernest Financial Advisors LLC

(3.4831%)

since

2025/06/30

2.

Morgan Stanley - Brokerage Accounts

(1.5067%)

since

2025/06/30

3.

Vanguard Group Inc

(0.8509%)

since

2025/06/30

4.

Geode Capital Management, LLC

(0.8227%)

since

2025/06/30

5.

Renaissance Technologies Corp

(0.6796%)

since

2025/06/30

6.

Vanguard Institutional Extnd Mkt Idx Tr

(0.6064%)

since

2025/07/31

7.

Essex Investment Management Company, LLC

(0.4712%)

since

2025/06/30

8.

Massey, Quick & Co. LLC

(0.4427%)

since

2025/06/30

9.

Fidelity Extended Market Index

(0.4089%)

since

2025/07/31

10.

Vanguard Total Stock Mkt Idx Inv

(0.3111%)

since

2025/07/31

11.

State Street Corp

(0.2139%)

since

2025/06/30

12.

Fidelity Total Market Index

(0.1694%)

since

2025/07/31

13.

XTX Topco Ltd

(0.1429%)

since

2025/06/30

14.

IFP Advisors, LLC

(0.1363%)

since

2025/06/30

15.

Malaga Cove Capital, LLC

(0.1289%)

since

2025/06/30

16.

Essex Inv Mgt Micro Cap Growth

(0.111%)

since

2025/03/31

17.

Fidelity Series Total Market Index

(0.1075%)

since

2025/07/31

18.

Spartan Extended Market Index Pool F

(0.0837%)

since

2025/07/31

19.

Northern Trust Extended Eq Market Idx

(0.0775%)

since

2025/06/30

20.

NT Ext Equity Mkt Idx Fd - L

(0.0775%)

since

2025/06/30

21.

Spartan Total Market Index Pool G

(0.0459%)

since

2025/07/31

22.

Dimensional US Core Equity 1 ETF

(0.0416%)

since

2025/08/29

23.

NT Ext Eq Mkt Indx Fd DC Lending Tier 5

(0.0219%)

since

2025/06/30

24.

NT Ext Eq Mkt Indx Fd DC Lend T3

(0.0185%)

since

2024/12/31

25.

DFA US Social Core Equity 2 Portfolio

(0.0152%)

since

2025/07/31

26.

Dimensional US Core Equity 2 ETF

(0.0106%)

since

2025/08/29

27.

Fidelity Nasdaq Composite Index

(0.0068%)

since

2025/07/31

28.

Advisor Group Holdings, Inc.

(0.0038%)

since

2025/06/30

29.

DFA US Micro Cap I

(0.0025%)

since

2025/07/31

30.

DFA US Small Cap I

(0.0019%)

since

2025/07/31

31.

Dimensional US Small Cap ETF

(0.0018%)

since

2025/08/29

32.

Bank of America Corp

(0.0007%)

since

2025/06/30

33.

Fidelity U.S. Equity Index Ins Trust

(0.0006%)

since

2025/07/31

34.

Goss Wealth Management LLC

(0.0002%)

since

2025/06/30

35.

SBI Securities Co Ltd

(0.0001%)

since

2025/06/30

36.

UBS Group AG

(0%)

since

2025/06/30

37.

Tower Research Capital LLC

(0%)

since

2025/03/31

38.

JPMorgan Chase & Co

(0%)

since

2025/06/30

39.

Flaharty Asset Management, LLC

(0%)

since

2025/06/30

40.

Virtu Financial LLC

(0%)

since

2025/03/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

0.02

Latest Release

Date

2025-09-30

EPS Actual

-0.08

EPS Estimate

-0.01

EPS Difference

-0.07

Surprise Percent

-700%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Weak Deep Value(2)
Defensive
Moderately Defensive(6)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(3.8)
GARP
Not Attractive for GARP(1.5)
Growth
Weak Growth Prospect(1)
Momentum
No Momentum(3)
Net Net
Not Undervalued (Net-Net)(1)
Quality
Low Quality Business(2)
Value
Fair Value(3.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.